Issued Patents All Time
Showing 1–15 of 15 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12011449 | Therapeutic combinations comprising a c-RAF inhibitor | Vesselina Cooke, Matthew John Meyer, Darrin Stuart | 2024-06-18 |
| 11406627 | Combinations of MDM2 inhibitors with inhibitors of ERK for treating cancers | Ensar Halilovic, Kelli-Ann Monaco | 2022-08-09 |
| 11376239 | Pharmaceutical combinations | Zhu Alexander Cao | 2022-07-05 |
| 10973829 | Therapeutic uses of a C-RAF inhibitor | Vesselina Cooke, Matthew John Meyer, Darrin Stuart | 2021-04-13 |
| 10548894 | Combination therapy | Darrin Stuart, Laure De Parseval | 2020-02-04 |
| 10485788 | Pharmaceutical combinations | Zhu Alexander Cao | 2019-11-26 |
| 10328066 | Pharmaceutical combination comprising the PI3K inhibitor alpelisib and the CDK4/6 inhibitor ribociclib, and the use thereof in the treatment/prevention of cancer | Thomas HORN-SPIROHN, Joseph Lehar | 2019-06-25 |
| 10328065 | Pharmaceutical combination comprising the PI3K inhibitor alpelisib and the B-RAF inhibitor dabrafenib; the use of such combination in the treatment or prevention of cancer | Thomas HORN-SPIROHN, Joseph Lehar | 2019-06-25 |
| 10011874 | Androgen receptor mutation | Vesselina Cooke, Scott Delach, Joshua Korn, Manav Korpal, Wenlai Zhou +1 more | 2018-07-03 |
| 9913844 | Combination therapy | Darrin Stuart, Laure De Parseval | 2018-03-13 |
| 9867825 | Pharmaceutical combination comprising binimetinib | Scott Delach, Shivang Doshi, Thomas HORN-SPIROHN, Sunkyu Kim | 2018-01-16 |
| 9700557 | Pharmaceutical combinations of a CDK4/6 inhibitor and a B-RAF inhibitor | Darrin Stuart, Sunkyu Kim, Alice Loo, Scott Delach | 2017-07-11 |
| 9474754 | Pharmaceutical combinations comprising a B-RAF inhibitor, and EGFR inhibitor and optionally a PI3K-α inhibitor | Darrin Stuart, Laure Moutouh-De Parseval | 2016-10-25 |
| 6623922 | Methods for identifying, characterizing, and evolving cell-type specific CIS regulatory elements | Carl Alexander Kamb | 2003-09-23 |
| 6582899 | Methods for identifying agents that cause a lethal phenotype, and agents thereof | Carl Alexander Kamb | 2003-06-24 |